 |
Verve Therapeutics
Last updated: August 03, 2025
Sekar Kathiresan, CEO
USA | Funding: $419.3M (+)
Website: https://www.vervetx.com/
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
Website: https://www.vervetx.com/
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
